OMC
PMVP icon

OUP Management Company’s PMV Pharmaceuticals PMVP Stock Holding History

OUP Management Company’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$6.07M Hold
989,232
– – 13.66% 4
2023
Q2 		$6.19M Hold
989,232
– – 10.56% 5
2023
Q1 		$4.72M Hold
989,232
– – 9.42% 4
2022
Q4 		$8.61M Hold
989,232
– – 14.05% 3
2022
Q3 		$11.8M Hold
989,232
– – 18.33% 2
2022
Q2 		$14.1M Hold
989,232
– – 19.4% 2
2022
Q1 		$20.6M Hold
989,232
– – 15.68% 3
2021
Q4 		$22.9M Buy
+989,232
New +$23.9M 10.3% 4

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OUP Management Company's PMVP Position: Q3 2023 in Review

OUP Management Company held its PMV Pharmaceuticals (PMVP) position steady in Q3 2023 at 989,232 shares worth $6.07M. The position accounts for 13.66% of the portfolio, ranked #4.

OUP Management Company first reported a position in PMVP in Q4 2021 and has held it in 8 quarters since. The position peaked at $22.9M in Q4 2021. 104 funds tracked by Wall St. Rank hold PMVP as of Q3 2023.

  • OUP Management Company held 989,232 shares of PMV Pharmaceuticals worth $6.07M as of Q3 2023.
  • OUP Management Company left its PMV Pharmaceuticals share count unchanged in Q3 2023.
  • PMV Pharmaceuticals made up 13.66% of OUP Management Company's portfolio in Q3 2023, its #4 holding.
  • OUP Management Company first reported a position in PMV Pharmaceuticals in Q4 2021 and has held it in 8 quarters since.
  • OUP Management Company's PMV Pharmaceuticals position peaked at $22.9M in Q4 2021.
  • 104 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.